首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Regional immunotherapy in resectable squamous cell lung carcinoma
Authors:N Roeslin  J M Lang  G Morand  J M Wihlm  J P Witz
Institution:(1) Service de Chirugie Thoracique, Hôpital Civil, F-67091 Strasbourg Cedex;(2) Service des Maladies du Sang, Hôpital Hautepierre, F-67091 Strasbourg, France
Abstract:Summary Patients with resectable squamous cell carcinoma were randomly allocated after surgery to receive either no further treatment (57 patients) or a single intrapleural injection of BCG (61 patients). No significant improvement in survival was observed in patients treated with BCG, even when their disease was staged as N0. These was a slight trend for the recurrence rate to be lower in patients classed as N0, but this was not significant.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号